Completed OBSERVATIONAL NCT05384470

Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry

Sponsor: Mclean Hospital

Conditions Diagnostic Marijuana Abuse Opiate Abuse

Interventions BID2 Instrument - breathalyzer Marihuana

Updated 6 times since 2022 Last updated: Apr 29, 2025 Started: Aug 1, 2021 Primary completion: Mar 19, 2024 Completion: Aug 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diagnostic and Marijuana Abuse, this trial is completed. The trial is conducted by Mclean Hospital and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Completed

Status: Recruiting → Completed · Phase: PHASE2 → None
Sep 2024 — Jun 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Feb 2024 — Jul 2024 [monthly]

Recruiting PHASE2
Jul 2022 — Feb 2024 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Jun 2022 — Jul 2022 [monthly]

Recruiting PHASE2

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mclean Hospital
VOX BIOMEDICAL LLC

Data source: Mclean Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belmont, United States